Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hadden

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Neurology|April 28, 2017
The nonsystemic vasculitic neuropathiesMichael P Collins, Robert D Hadden
Current Opinion in Neurology|December 11, 1999
Treatment of immune-mediated inflammatory neuropathiesR D Hadden, R A Hughes
Hospital Medicine (London, England : 1998)|November 3, 1998
Guillain-Barré syndrome: recent advancesR D Hadden, R A Hughes
Early Human Development|June 15, 1999
The effect of early feeding on the neonatal blood glucose level at 1-hour of ageD G Sweet, D Hadden, H L Halliday
The Journal of Pathology|July 1, 1990
Clinical, biochemical and immunoelectron microscopical evidence of dual hormone production in a mammosomatotroph cell adenomaS Cameron, I Allen, C Ozo, et al.
Journal of Neuroimmunology|March 1, 2000
Pathogenesis of Guillain-Barré syndromeR A Hughes, R D Hadden, N A Gregson, et al.
Journal of the Peripheral Nervous System : JPNS|March 25, 2018
Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathiesJeffrey A Allen, Melvin Berger, Luis Querol, et al.
Neurology|July 17, 1999
Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathyR D Hadden, B Sharrack, S Bensa, et al.
European Journal of Neurology|September 6, 2000
Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot studyS Bensa, R D Hadden, A Hahn, et al.
Journal of Neuroimmunology|October 5, 2001
Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritisR D Hadden, N A Gregson, R Gold, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Neurology|April 28, 2017
The nonsystemic vasculitic neuropathiesMichael P Collins, Robert D Hadden
Current Opinion in Neurology|December 11, 1999
Treatment of immune-mediated inflammatory neuropathiesR D Hadden, R A Hughes
Hospital Medicine (London, England : 1998)|November 3, 1998
Guillain-Barré syndrome: recent advancesR D Hadden, R A Hughes
Early Human Development|June 15, 1999
The effect of early feeding on the neonatal blood glucose level at 1-hour of ageD G Sweet, D Hadden, H L Halliday
The Journal of Pathology|July 1, 1990
Clinical, biochemical and immunoelectron microscopical evidence of dual hormone production in a mammosomatotroph cell adenomaS Cameron, I Allen, C Ozo, et al.
Journal of Neuroimmunology|March 1, 2000
Pathogenesis of Guillain-Barré syndromeR A Hughes, R D Hadden, N A Gregson, et al.
Journal of the Peripheral Nervous System : JPNS|March 25, 2018
Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathiesJeffrey A Allen, Melvin Berger, Luis Querol, et al.
Neurology|July 17, 1999
Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathyR D Hadden, B Sharrack, S Bensa, et al.
European Journal of Neurology|September 6, 2000
Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot studyS Bensa, R D Hadden, A Hahn, et al.
Journal of Neuroimmunology|October 5, 2001
Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritisR D Hadden, N A Gregson, R Gold, et al.
Pageof 3